Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus
NCT04970199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2022-01-28
Summary
Systemic lupus erythematosus is a chronic and multisystemic autoimmune disorder which predominantly affecting women. The most common cause of death in lupus patients affected by disease for more than 5 years is cardiovascular disease due to presence of some factors as oxidative stress, pro-inflammatory cytokines , dyslipidemia, diabetes, and hypertension.
Conditions
- System; Lupus Erythematosus
Interventions
- DEVICE
-
laser application on acupoints
laser acupuncture
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Ali Ismail, lecturer · Cairo University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 47 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-12
- Primary Completion
- 2021-11-10
- Completion
- 2021-11-30
Countries
- Egypt
Study Locations
More Related Trials
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
SLE Vasculitis In Egyptian Patients
NCT04386889 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases
NCT06169865 ·Status: RECRUITING
-
Immune Adsorption Role in Treatment of Resistant Lupus
NCT04108611 ·Status: COMPLETED ·Phase: NA
-
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT00985803 ·Status: UNKNOWN ·Phase: PHASE1
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
Flow Mediated Dilation in Association With Hyperuricemia
NCT05342285 ·Status: UNKNOWN
-
Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
NCT04024306 ·Status: UNKNOWN
-
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
NCT06491602 ·Status: RECRUITING
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study
NCT04431167 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety of Acupuncture for Systemic Lupus
NCT00493753 ·Status: COMPLETED ·Phase: NA
-
A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
NCT00982670 ·Status: COMPLETED
-
Systemic Lupus Erythematous and Heart Conduction Disorders
NCT02162992 ·Status: COMPLETED
-
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
NCT05964751 ·Status: UNKNOWN
-
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
NCT06151990 ·Status: RECRUITING
-
The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis
NCT05714670 ·Status: COMPLETED ·Phase: PHASE2
-
Fatigue, Depression, and Cortical Excitability in Systemic Lupus
NCT03165682 ·Status: UNKNOWN
-
Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus
NCT05853003 ·Status: COMPLETED
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
NCT04440566 ·Status: COMPLETED ·Phase: NA
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Topical Nicotinamide in Treatment of DLE
NCT05362188 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Identifying New Therapeutic Targets for Lupus Treatment
NCT03921398 ·Status: COMPLETED